Thiol-vinyl and thiol-yne systems for shape memory polymers
A variety of biomedical devices are provided which include thiol-ene or thiol-yne shape memory polymers. The biomedical devices of the invention are capable of exhibiting shape memory behavior at physiological temperatures and may be used in surgical procedures. Methods of making the devices of the invention are also provided.
1. A medical device for in vivo medical applications comprising a shape memory polymer formed by polymerization of a mixture comprising:
a first monomer which does not homopolymerize and which has the structure of
a second monomer or oligomer comprising at least three thiol groups; and
an optional third monomer or oligomer comprising at least one aliphatic carbon-carbon double bond
wherein the glass transition temperature of the polymer is from 25° C. to 45° C. and the strain to failure of the shape memory polymer is at least 40% as measured at 20-25° C.
2. The device of claim 1 , wherein the third monomer or oligomer is homopolymerizable.
3. The device of claim 2 , wherein the third monomer or oligomer comprises a plurality of urethane groups and a plurality of acrylate groups.
4. The device of claim 1 , wherein the second monomer comprises from 2 to 6 thiourethane groups.
5. The device of claim 1 wherein the second monomer or oligomer is formed by reacting a polyisocyanate with a plurality of molecules comprising at least three thiol groups.
6. The device of claim 5 wherein the second monomer is a mixture of the reaction products of 2 equivalents of pentaerythritol tetra(3-mercaptopropionate) to 1 equivalent of isophorone diisocyanate.
7. The device of claim 1 , wherein the device is an endoluminal prosthesis.
8. The device of claim 1 , wherein the molar ratio of thiol groups in the mixture is from 30-70% and the molar ratio of aliphatic carbon-carbon double bonds and aliphatic carbon-carbon triple bonds groups in the mixture is from 70% to 30%.
9. The device of claim 2 , wherein the thiol groups and non-homopolymerizable aliphatic carbon-carbon double bonds and aliphatic carbon-carbon triple bonds constitute greater than 30 mol % of the mixture.
10. The device of claim 1 , wherein the molecular weight of the first monomer is from 200 to 2000.
11. The device of claim 1 , wherein the molecular weight of the second monomer is from 200 to 2000.
12. The device of claim 1 wherein the shape memory polymer is biodegradable.
13. The device of claim 12 , wherein the shape memory polymer degrades by hydrolysis by exposure to water or enzymes under physiological conditions.
14. A medical device for in vivo medical applications comprising a shape memory polymer formed by polymerization of a mixture comprising:
a first monomer or oligomer comprising at least three aliphatic carbon-carbon double bonds or at least three aliphatic carbon-carbon triple bonds;
a second monomer or oligomer comprising at least six thiol functional groups; and
an optional third monomer or oligomer comprising at least one aliphatic carbon-carbon double bond
wherein at least one of the monomers or oligomers in the mixture further comprises at least one urethane or thiourethane group, the glass transition temperature of the polymer is from 25° C. to 45° C. and the strain to failure of the shape memory polymer is at least 40% as measured at 20-25° C.
15. The medical device of claim 1 wherein the first monomer has the following structure:
16. The medical device of claim 1 wherein the first monomer has the following structure: